Cargando…

Monitoring Insulin Aggregation via Capillary Electrophoresis

Early stages of insulin aggregation, which involve the transient formation of oligomeric aggregates, are an important aspect in the progression of Type II diabetes and in the quality control of pharmaceutical insulin production. This study is the first to utilize capillary electrophoresis (CE) with...

Descripción completa

Detalles Bibliográficos
Autores principales: Pryor, Elizabeth, Kotarek, Joseph A., Moss, Melissa A., Hestekin, Christa N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257135/
https://www.ncbi.nlm.nih.gov/pubmed/22272138
http://dx.doi.org/10.3390/ijms12129369
_version_ 1782221111383031808
author Pryor, Elizabeth
Kotarek, Joseph A.
Moss, Melissa A.
Hestekin, Christa N.
author_facet Pryor, Elizabeth
Kotarek, Joseph A.
Moss, Melissa A.
Hestekin, Christa N.
author_sort Pryor, Elizabeth
collection PubMed
description Early stages of insulin aggregation, which involve the transient formation of oligomeric aggregates, are an important aspect in the progression of Type II diabetes and in the quality control of pharmaceutical insulin production. This study is the first to utilize capillary electrophoresis (CE) with ultraviolet (UV) detection to monitor insulin oligomer formation at pH 8.0 and physiological ionic strength. The lag time to formation of the first detected species in the aggregation process was evaluated by UV-CE and thioflavin T (ThT) binding for salt concentrations from 100 mM to 250 mM. UV-CE had a significantly shorter (5–8 h) lag time than ThT binding (15–19 h). In addition, the lag time to detection of the first aggregated species via UV-CE was unaffected by salt concentration, while a trend toward an increased lag time with increased salt concentration was observed with ThT binding. This result indicates that solution ionic strength impacts early stages of aggregation and β-sheet aggregate formation differently. To observe whether CE may be applied for the analysis of biological samples containing low insulin concentrations, the limit of detection using UV and laser induced fluorescence (LIF) detection modes was determined. The limit of detection using LIF-CE, 48.4 pM, was lower than the physiological insulin concentration, verifying the utility of this technique for monitoring biological samples. LIF-CE was subsequently used to analyze the time course for fluorescein isothiocyanate (FITC)-labeled insulin oligomer formation. This study is the first to report that the FITC label prevented incorporation of insulin into oligomers, cautioning against the use of this fluorescent label as a tag for following early stages of insulin aggregation.
format Online
Article
Text
id pubmed-3257135
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Molecular Diversity Preservation International (MDPI)
record_format MEDLINE/PubMed
spelling pubmed-32571352012-01-23 Monitoring Insulin Aggregation via Capillary Electrophoresis Pryor, Elizabeth Kotarek, Joseph A. Moss, Melissa A. Hestekin, Christa N. Int J Mol Sci Article Early stages of insulin aggregation, which involve the transient formation of oligomeric aggregates, are an important aspect in the progression of Type II diabetes and in the quality control of pharmaceutical insulin production. This study is the first to utilize capillary electrophoresis (CE) with ultraviolet (UV) detection to monitor insulin oligomer formation at pH 8.0 and physiological ionic strength. The lag time to formation of the first detected species in the aggregation process was evaluated by UV-CE and thioflavin T (ThT) binding for salt concentrations from 100 mM to 250 mM. UV-CE had a significantly shorter (5–8 h) lag time than ThT binding (15–19 h). In addition, the lag time to detection of the first aggregated species via UV-CE was unaffected by salt concentration, while a trend toward an increased lag time with increased salt concentration was observed with ThT binding. This result indicates that solution ionic strength impacts early stages of aggregation and β-sheet aggregate formation differently. To observe whether CE may be applied for the analysis of biological samples containing low insulin concentrations, the limit of detection using UV and laser induced fluorescence (LIF) detection modes was determined. The limit of detection using LIF-CE, 48.4 pM, was lower than the physiological insulin concentration, verifying the utility of this technique for monitoring biological samples. LIF-CE was subsequently used to analyze the time course for fluorescein isothiocyanate (FITC)-labeled insulin oligomer formation. This study is the first to report that the FITC label prevented incorporation of insulin into oligomers, cautioning against the use of this fluorescent label as a tag for following early stages of insulin aggregation. Molecular Diversity Preservation International (MDPI) 2011-12-14 /pmc/articles/PMC3257135/ /pubmed/22272138 http://dx.doi.org/10.3390/ijms12129369 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Pryor, Elizabeth
Kotarek, Joseph A.
Moss, Melissa A.
Hestekin, Christa N.
Monitoring Insulin Aggregation via Capillary Electrophoresis
title Monitoring Insulin Aggregation via Capillary Electrophoresis
title_full Monitoring Insulin Aggregation via Capillary Electrophoresis
title_fullStr Monitoring Insulin Aggregation via Capillary Electrophoresis
title_full_unstemmed Monitoring Insulin Aggregation via Capillary Electrophoresis
title_short Monitoring Insulin Aggregation via Capillary Electrophoresis
title_sort monitoring insulin aggregation via capillary electrophoresis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3257135/
https://www.ncbi.nlm.nih.gov/pubmed/22272138
http://dx.doi.org/10.3390/ijms12129369
work_keys_str_mv AT pryorelizabeth monitoringinsulinaggregationviacapillaryelectrophoresis
AT kotarekjosepha monitoringinsulinaggregationviacapillaryelectrophoresis
AT mossmelissaa monitoringinsulinaggregationviacapillaryelectrophoresis
AT hestekinchristan monitoringinsulinaggregationviacapillaryelectrophoresis